PENNY BROWN: Open Payments
NPI 1245216449 · AHOSKIE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 38 payments from 14 companies in 2025. Trend: 2023 $976 · 2024 $837 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $135 |
| PFIZER INC. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| ABBVIE INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
| Corcept Therapeutics | 2 | $41 |
| Bioventus LLC | 1 | $33 |
| Amgen Inc. | 2 | $31 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: NURTEC ODT, UBRELVY, AIRSUPRA, Rybelsus, JARDIANCE, Ozempic, Wegovy, Korlym.
Industry payments across NC — which companies pay providers there.
